Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: A gender-related study

Epilepsia

Volumn 40, Issue 4, 1999, Pages 480-484

  Sudhop, T ^a   Bauer, J ^a   Elger, C E ^a   Von Bergmann, K ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Carbamazepine; Gender; HDL cholesterol; Lipoproteins

Indexed keywords

CARBAMAZEPINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LATHOSTEROL;

ADULT; AGED; ARTICLE; ATHEROGENESIS; CATABOLISM; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; DRUG EFFECT; ENZYME INDUCTION; EPILEPSY; FEMALE; HUMAN; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0032934981     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1999.tb00744.x     Document Type: Article

References (32)

1. Luoma PV, Sotaniemi EA. Pelkonen RO, Pirttiaho HI. Serum low-density lipoprotein and high-density lipoprotein cholesterol, and liver size in subjects on drugs inducing hepatic microsomal enzymes. Eur J Clin Pharmacol 1985;28:615-8.
2. Brown DW. Ketter TA, Crumlish J, Post RM. Carbamazepine-induced increases in total serum cholesterol: clinical and theoretical implications. J Clin Psyckopharmacol 1992:12:431-7.
3. Calandre EP. Rodriguez-Lopez C, Blazquez A, Cano D. Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital. Acta Neurol Scand 1991;83:250-3.
4. Isojärvi JI, Pakarinen AJ, Myllyla VV. Serum lipid levels during carbamazepine medication: a prospective study. Arch Neurol 1993; 50:590-3.
5. Zeitlhofer J, Doppelbauer A, Tribl G, Leitha T, Deecke L. Changes of serum lipid patterns during long-term anticonvulsive tre-atment. Clin Invest 1993;71:574-8.
6. Reddy MN. Effect of anticonvulsant drugs on plasma total cholesterol, high-density lipoprotein cholesterol, and apolipoproteins A and B in children with epilepsy. Proc Soc Exp Biol Med 1985; 180:359-63.
7. Heldenberg D, Harel S, Holtzman M, Levtow O, Tamir I. The effect of chronic anticonvulsant therapy on serum lipids and lipoproteins in epileptic children. Neurology 1983;33:510-3.
8. Franzoni E, Govoni M, D'Addato S, et al. Total cholesterol, high-density lipoprotein cholesterol, and triglycérides in children receiving antiepileptic drugs. Epilepsia 1992;33:932-5.
9. Eiris JM, Lojo S, Del Rio MC, et al. Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy. Neurology 1995;45:1155-7.
10. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannet WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986;256:2835-8.
11. Assmann G, Funke H. HDL metabolism and atherosclerosis. J Cardiovasc Pharmacol 1990;16(suppl 9):S15-20.
12. Livingston S. Phenytoin and serum cholesterol [Letter]. Br Med J 1976;586:586.
13. Muuronen A, Kaste M, Nikkila EA, Tolppanen EM. Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study. Br Med J Clin Res Ed 1985;291:1481-3.
14. Erilä T. Epileptikkojen kuolleisuus Suomessa vuosina 1967-1973. [Summary in English: Mortality of patients with epilepsy in Finnland 1967-1973]. Acte Univ Tamperensis Ser A 1982;145:1-167.
15. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. Am J Med 1977;62:707-14.
16. Anderson KM, Wilson PW, Garrison RJ, Castelli WP. Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample: The Framingham Offspring Study. Atherosclerosis 1987;68:59-66.
17. Assmann G, Schulte H. The importance of triglycerides: results from the Prospective Cardiovascular Munster (PROCAM) Study. Eur J Epidemiol 1992;8(suppl 1):99-103.
18. Isojarvi JI. Pakarinen AJ, Rautio A, Pelkonen O, Myllyla VV. Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine. Epilepsia 1994;35:1217-20.
19. Kerr BM, Thummel KE, Wurden CJ, et al. Human liver carbamazepine metabolism: role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem Pharmacol 1994;47:1969-79.
20. Pirmohamed M, Kitteringham NR, Breckenridge AM, Park BK. The effect of enzyme induction on the cytochrome P450-mediated bioactivation of carbamazepine by mouse liver microsomes. Biochem Pharmacol 1992;44:2307-14.
21. Pirmohamed M, Kitteringham NR, Guenthner TM, Breckenridge AM, Park BK. An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitro. Biochem Pharmacol 1992;43:1675-82.
22. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
23. Heinemann T, Kullak Ublick GA, Pietruck B, von Bergmann K. Mechanisms of action of plant sterols on inhibition of cholesterol absorption: comparison of sitosterol and sitostanol. Eur J Clin Pharmacol 1991 ;40(suppl 1):S59-63.
24. Björkhem I, Miettinen T, Reihner E, Ewerth S, Angelin B, Einarsson K. Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J Lipid Res 1987;28:1137-43.
25. Yalcin E, Hassanzadeh A, Mawlud K. The effects of long-term anticonvulsive treatment on serum lipid profile. Acta Paediatr Jpn 1997;39:342-5.
26. Verrotti A, Domizio S, Angelozzi B, Sabatino G, Morgese G, Chiarelli F. Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants. J Paediatr Child Health 1997;33:242-5.
27. Sozuer DT, Atakil D, Dogu O. Baybas S, Arpaci B. Serum lipids in epileptic children treated with carbamazepine and valproate. Eur J Pediatr 1997; 156:565-7.
28. Hindi AJ, Al-Shamma GA, Al-Jadiry AMH, Zaidan ZAJ, Al-Hussainy T. Serum lipids in epileptic patients receiving carbamazepine; effect of age, sex and serum concentration. Med Sci Res 1989;17:155-6.
29. Brinton EA, Eisenberg S, Breslow JL. Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women. J Clin Invest 1989;84:262-9.
30. Coyne MJ, Bonorris GG, Goldstein LI, Schoenfield LJ. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones. J Lab Clin Med 1976;87:281-91.
31. Miller GJ, Miller NE. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1975;1: 16-9.
32. Luoma PV. Microsomal enzyme induction, lipoproteins and atherosclerosis. Pharmacol Toxicol 1988;62:243-9.